The effects of genomic variations and their associations with idiopathic scoliosis have been the discussion of many research trials. Previous investigations into catechol-o-methyl transferase (COMT) have identified its importance in dopamine and estrogen metabolism. While many genetic influences on idiopathic scoliosis have been observed, there has been no report of any relationship between COMT mutations and idiopathic scoliosis. The present study compared two groups of patients who received COMT genetic testing. The first group had a history of idiopathic scoliosis, while the other served as a non-scoliotic control group. The scoliosis group showed a positive COMT mutation in 33 out of 58 patients, while the control group showed 22/58 (P < 0.05). The homozygous genotype Met/Met occurred significantly more frequently in the scoliosis group. The increased incidence of COMT defects in the current scoliosis patient group warrants further study into how COMT variations may relate to the development or progression of idiopathic scoliosis.
Introduction
There has been significant interest and investigation into the genetic contributions to the development and/or progression of idiopathic scoliosis. For example, genome-wide association studies [1] [2] and systematic reviews [3] [4] [5] How to cite this paper: Morningstar have been published, in hopes of identifying any associations with adolescent idiopathic scoliosis. Although many single nucleotide polymorphisms have been previously identified, several of these have been excluded upon further investigation [6] . With many neuro-hormonal aspects of idiopathic scoliosis now identified [7] , it is likely that interest in possible genetic contributions to idiopathic scoliosis will continue into the forseeable future.
Previous studies have described hormonal and neurotransmitter imbalances in patients with idiopathic scoliosis. For example, studies have suggested a relationship between melatonin and estrogen communication with osteoblast cells in patients with adolescent idiopathic scoliosis [8] [9] . At the core of many of these hormonal pathways is the methylation cycle. Previously, Morningstar et al.
showed that patients with idiopathic scoliosis had a higher rate of methylenetetrahydrofolate reductase (MTHFR) polymorphism of the A1298C allele compared with non-scoliotic controls [10] . Another enzyme in the methylation cycle, catechol-O-methyl transferase (COMT) degrades catecholamine neurotransmitters (dopamine, norepinephrine, and epinephrine) into their constituent metabolites. This catecholamine degradation occurs by transferring a methyl group from a methyl donor, such as s-adenosyl methionine (SAMe) [Juarez] .
COMT also breaks down estrone and estradiol into their respective metabolitesvia this same methyl donation and transfer process. Reduced estrogen breakdown activity by COMT is thought to contribute to cancer risk [11] . Given its importance in dopamine and estrogen metabolism, combined with previously published studies examining these chemicals relative to scoliosis etiopathogenesis [12] [13] , this study examined the rate of occurrence of COMT polymorphisms in a cohort of patients with idiopathic scoliosis compared to a group of non-scoliotics. To date, no study has reported the presence of a COMT genetic variant in patients with idiopathic scoliosis.
Materials and Methods
Patient charts from a single medical office were examined and pulled for patients who presented with a history of scoliosis. Once these patient files were identified, those that fulfilled the following inclusion criteria were included in the were ultimately selected for study. All of these files were selected from the author's (MNS) integrative medicine clinic.
After these patient charts were selected, another group of 58 patient charts was identified. These patients had presented to the same medical office, had the same type of genetic testing performed for non-scoliosis diagnoses, but were negative for scoliosis. This group of charts served as the control group. For purposes of this study, patients were considered positive for the COMT genetic variant if they met the following positive criteria: 1) a double mutation of COMT Val158Met (homozygous positive), or 2) a single mutation (heterozygous positive). These results were recorded for all patients in both groups, and then compared using single factor ANOVA testing. Patients in both groups whose charts were selected subsequently provided written permission to use their non-identifying lab results and demographics.
Results
In the scoliosis group, 41 of the 58 patients were Caucasian, 7 were African-American, 5 were Hispanic, and 5 were Indian. homozygous. This information is shown in Table 2 . These differences were statistically significant (P < 0.05). When comparing the differences of each genotype between the two groups using independent t-tests, the Val/Val (normal) genotype was significantly higher (P < 0.05) than the scoliosis group. Conversely, the scoliosis group showed a significantly higher level (P < 0.05) occurrence of the Met/Met genotype, 2.7 times more frequently than the control group. A power analysis, given the mean and standard deviation, showed that a sample size of 56 would achieve 80% power.
Discussion
Morningstar et al. previously observed that urinary norepinephrine levels tend to be elevated in patients with idiopathic scoliosis compared to non-scoliotics [14] . Since it has been recognized that the Val allele expression may predispose patients to poorer motor learning [15] , it is possible that this genetic variant may prefrontal levels of dopamine [15] , which is directly converted into norepinephrine downstream. Therefore, this genetic variant may be responsible for the downstream elevation seen in peripheral urinary norepinephrine levels previously observed [14] .
It may be noteworthy to discuss the potential implications of the distinct difference in the amount of homozygous variants in the scoliosis group (n = 19) compared to the control group (n = 7). Since idiopathic scoliosis appears to be multi-factorial [7] , the Met/Met genotype needs to be further explored, as some of the etiological theories may be explained, at least in part, by this COMT ge- 
Limitations
Although the patients in the control group for the present study did not have scoliosis, they were nonetheless patients begin treated for other health issues and symptoms. Therefore, the control group used in this study may not necessarily be considered healthy controls. Additionally, it is possible that some of the symptoms for which they were being treated may have at least partially been the downstream result of the COMT variant in those control patients who were positive for it. Finally, while the scoliosis population selected in this study showed a significantly higher proportion of people with a positive COMT variant, this does not necessarily indicate that the COMT gene variant is a cause or contributing factor for the onset or progression of scoliosis. Selection bias may also affect the study results, although attempts were made to select every possible patient within the same time period.
Conclusion
In two different clinical samples of patient records, 57% of patients with a history of idiopathic scoliosis tested positive for a COMT Val158Met genetic variation, as compared to 38% of a non-scoliotic control group. Within these percentages, the homozygous Met/Met genotype variant occurred significantly more frequently in the scoliosis group as compared to the non-scoliotic group. Given the importance of the COMT enzyme on catecholamine metabolism, this study further identifies the relationship between abnormal neurotransmitter metabolism and idiopathic scoliosis. However, it is unknown how abnormal catecholamine metabolism relates to idiopathic scoliosis in terms of causation or effect. Further investigation may help to better identify any causal relationships.
